BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,983,306 | +40.0% | 6,491,343 | +69.0% | 0.05% | +45.9% |
| Q2 2023 | $174,967,916 | +9.7% | 3,840,384 | -2.3% | 0.04% | +5.7% |
| Q1 2023 | $159,513,502 | -22.4% | 3,932,778 | -2.5% | 0.04% | -25.5% |
| Q4 2022 | $205,527,842 | -9.5% | 4,032,330 | -4.4% | 0.05% | -14.5% |
| Q3 2022 | $227,159,000 | -17.2% | 4,217,558 | -1.2% | 0.06% | -12.7% |
| Q2 2022 | $274,303,000 | -15.4% | 4,270,641 | +2.2% | 0.06% | 0.0% |
| Q1 2022 | $324,124,000 | -11.4% | 4,180,122 | -1.9% | 0.06% | -4.5% |
| Q4 2021 | $365,904,000 | +3.8% | 4,262,640 | -2.7% | 0.07% | -4.3% |
| Q3 2021 | $352,494,000 | -0.5% | 4,382,603 | -0.4% | 0.07% | 0.0% |
| Q2 2021 | $354,351,000 | -4.9% | 4,401,890 | -0.3% | 0.07% | -9.2% |
| Q1 2021 | $372,549,000 | +4.8% | 4,417,229 | -0.3% | 0.08% | -1.3% |
| Q4 2020 | $355,504,000 | +1.2% | 4,430,532 | +1.4% | 0.08% | -11.5% |
| Q3 2020 | $351,391,000 | -3.2% | 4,369,442 | +3.6% | 0.09% | -10.3% |
| Q2 2020 | $363,095,000 | +15.3% | 4,217,145 | +8.7% | 0.10% | -6.7% |
| Q1 2020 | $315,010,000 | -7.7% | 3,879,936 | -4.9% | 0.10% | +18.2% |
| Q4 2019 | $341,200,000 | -27.1% | 4,080,358 | -23.8% | 0.09% | -31.2% |
| Q3 2019 | $468,119,000 | +28.6% | 5,351,786 | +20.4% | 0.13% | +29.3% |
| Q2 2019 | $363,985,000 | +14.9% | 4,444,262 | +14.0% | 0.10% | +11.2% |
| Q1 2019 | $316,908,000 | +19.5% | 3,897,520 | -3.3% | 0.09% | +7.2% |
| Q4 2018 | $265,252,000 | -20.1% | 4,029,980 | -6.4% | 0.08% | -2.4% |
| Q3 2018 | $331,783,000 | +2.7% | 4,303,844 | -1.6% | 0.08% | -3.4% |
| Q2 2018 | $322,917,000 | +5.7% | 4,373,209 | -6.9% | 0.09% | +3.5% |
| Q1 2018 | $305,644,000 | -4.1% | 4,699,342 | -4.7% | 0.08% | +1.2% |
| Q4 2017 | $318,766,000 | +2.0% | 4,931,407 | -0.9% | 0.08% | -2.3% |
| Q3 2017 | $312,378,000 | +4.0% | 4,978,139 | +0.3% | 0.09% | +1.2% |
| Q2 2017 | $300,376,000 | +7.8% | 4,961,616 | -7.6% | 0.08% | +10.4% |
| Q1 2017 | $278,622,000 | +11.5% | 5,372,606 | -4.6% | 0.08% | +6.9% |
| Q4 2016 | $249,784,000 | -8.4% | 5,633,374 | -1.6% | 0.07% | -11.1% |
| Q3 2016 | $272,597,000 | +9.0% | 5,726,864 | +3.5% | 0.08% | +6.6% |
| Q2 2016 | $250,102,000 | +17.4% | 5,530,764 | +6.6% | 0.08% | +18.8% |
| Q1 2016 | $213,084,000 | -3.8% | 5,187,039 | -10.6% | 0.06% | -4.5% |
| Q4 2015 | $221,448,000 | -18.2% | 5,804,657 | -29.6% | 0.07% | -19.3% |
| Q3 2015 | $270,822,000 | -57.1% | 8,244,222 | -8.7% | 0.08% | -52.3% |
| Q2 2015 | $631,356,000 | -0.4% | 9,028,398 | -2.4% | 0.17% | +5.5% |
| Q1 2015 | $633,968,000 | -7.1% | 9,255,001 | -0.6% | 0.16% | -7.3% |
| Q4 2014 | $682,531,000 | +4.6% | 9,312,729 | +2.5% | 0.18% | +0.6% |
| Q3 2014 | $652,245,000 | -50.2% | 9,087,985 | -49.8% | 0.18% | +0.6% |
| Q2 2014 | $1,310,090,000 | +96.0% | 18,120,222 | +99.4% | 0.18% | -3.3% |
| Q1 2014 | $668,532,000 | +9.9% | 9,085,803 | +3.9% | 0.18% | +7.7% |
| Q4 2013 | $608,235,000 | -37.4% | 8,745,276 | -40.9% | 0.17% | +15.8% |
| Q3 2013 | $972,246,000 | +95.8% | 14,800,552 | +106.5% | 0.15% | -6.4% |
| Q2 2013 | $496,595,000 | – | 7,169,003 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |